(Reuters) - Johnson & Johnson said on Tuesday it has accepted private equity firm Platinum Equity's $2.1 billion buyout offer for the company's LifeScan Inc unit.
Platinum had given J&J until mid-June to accept the offer for the unit, which makes blood glucose monitoring products.
(Reporting by Uday Sampath in Bengaluru; Editing by Shailesh Kuber)
Disclaimer: No Business Standard Journalist was involved in creation of this content